Pamela Wilson email address & phone number | Puma Biotechnology, Inc. Sr VP, Clinical Operations contact information - RocketReach
Puma Biotechnology
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma Biotechnology, Inc. 2022 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology (Nasdaq:PBYI) - Stock Price, News & Analysis - Simply Wall St
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Surging
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Puma Biotechnology
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting
Pint-Pharma - Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America
ADAPTING
Chris Culotta - Associate Director, Accounting - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology, Inc. - SEC Filings - Annual Reports & Proxies
Praneeth C. - Clinical Data Management - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology, Inc. | LinkedIn
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology, Inc. | CDISC
Puma Biotechnology Inc Share Price USD0.0001
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
